Abbott Laboratories set for stellar Q4 2024 earnings amid optimism for 2025

by
Contributor since / Followers

15 hours ago

Abbott Laboratories (NYSE:ABT) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market opens.
Analysts remain largely bullish on the healthcare stock, citing the strength of its key growth businesses and scaling and operational execution.
RBC Capital

Tags: ABT